CELCUITY INC. Diluted Shares Outstanding (Weighted Average)
CELCUITY INC. (CELC) reported Diluted Shares Outstanding (Weighted Average) of 54.82 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-13
- CELCUITY INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 54.82M shares, a 25.54% increase year-over-year.
- CELCUITY INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 54.46M shares, a 26.50% increase year-over-year.
- CELCUITY INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 52.68M shares, a 22.79% increase year-over-year.
- CELCUITY INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 47.59M shares, a 11.21% increase year-over-year.
- CELCUITY INC. weighted average number of shares outstanding, diluted for fiscal 2025 was 46.76M shares, a 18.53% increase from fiscal 2024.
- CELCUITY INC. weighted average number of shares outstanding, diluted for fiscal 2024 was 39.45M shares, a 66.60% increase from fiscal 2023.
- CELCUITY INC. weighted average number of shares outstanding, diluted for fiscal 2023 was 23.68M shares, a 53.58% increase from fiscal 2022.
- CELCUITY INC. weighted average number of shares outstanding, diluted for fiscal 2022 was 15.42M shares.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | 54.82M shares 10-Q · filed 2026-08-13 | 54.64M shares 10-Q · filed 2026-08-13 | 53.98M shares derived: average of 3 quarters · filed 2026-08-13 | 52.39M shares derived: average of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | 54.46M shares 10-Q · filed 2026-05-14 | 53.57M shares derived: average of 2 quarters · filed 2026-05-14 | 51.58M shares derived: average of 3 quarters · filed 2026-05-14 | 49.60M shares derived: average of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | 52.68M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | 50.13M shares derived: average of 2 quarters · filed 2026-03-26 | 47.98M shares derived: average of 3 quarters · filed 2026-08-13 | 46.76M shares 10-K · filed 2026-03-26 |
| 2025-09-30 | 47.59M shares 10-Q · filed 2025-11-13 | 45.63M shares derived: average of 2 quarters · filed 2026-08-13 | 44.79M shares 10-Q · filed 2025-11-13 | 44.30M shares derived: average of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | 43.66M shares 10-Q · filed 2026-08-13 | 43.36M shares 10-Q · filed 2026-08-13 | 43.21M shares derived: average of 3 quarters · filed 2026-08-13 | 43.10M shares derived: average of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | 43.05M shares 10-Q · filed 2026-05-14 | 42.98M shares derived: average of 2 quarters · filed 2026-05-14 | 42.91M shares derived: average of 3 quarters · filed 2026-05-14 | 41.80M shares derived: average of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | 42.90M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | 42.85M shares derived: average of 2 quarters · filed 2026-03-26 | 41.38M shares derived: average of 3 quarters · filed 2026-03-26 | 39.45M shares 10-K · filed 2026-03-26 |
| 2024-09-30 | 42.79M shares 10-Q · filed 2025-11-13 | 40.62M shares derived: average of 2 quarters · filed 2025-11-13 | 38.30M shares 10-Q · filed 2025-11-13 | 35.95M shares derived: average of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | 38.44M shares 10-Q · filed 2025-08-14 | 36.03M shares 10-Q · filed 2025-08-14 | 33.67M shares derived: average of 3 quarters · filed 2025-08-14 | 30.78M shares derived: average of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | 33.61M shares 10-Q · filed 2025-05-15 | 31.28M shares derived: average of 2 quarters · filed 2025-05-15 | 28.23M shares derived: average of 3 quarters · filed 2025-05-15 | 26.66M shares derived: average of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | 28.96M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | 25.54M shares derived: average of 2 quarters · filed 2025-03-31 | 24.34M shares derived: average of 3 quarters · filed 2025-03-31 | 23.68M shares 10-K · filed 2025-03-31 |
| 2023-09-30 | 22.12M shares 10-Q · filed 2024-11-14 | 22.04M shares derived: average of 2 quarters · filed 2024-11-14 | 21.92M shares 10-Q · filed 2024-11-14 | 20.66M shares derived: average of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | 21.96M shares 10-Q · filed 2024-08-14 | 21.82M shares 10-Q · filed 2024-08-14 | 20.18M shares derived: average of 3 quarters · filed 2024-08-14 | 18.87M shares derived: average of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | 21.68M shares 10-Q · filed 2024-05-15 | 19.28M shares derived: average of 2 quarters · filed 2024-05-15 | 17.84M shares derived: average of 3 quarters · filed 2024-05-15 | 17.11M shares derived: average of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | 16.89M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | 15.91M shares derived: average of 2 quarters · filed 2024-03-27 | 15.59M shares derived: average of 3 quarters · filed 2024-03-27 | 15.42M shares 10-K · filed 2024-03-27 |
| 2022-09-30 | 14.94M shares 10-Q · filed 2023-11-13 | 14.93M shares derived: average of 2 quarters · filed 2023-11-13 | 14.93M shares 10-Q · filed 2023-11-13 | |
| 2022-06-30 | 14.93M shares 10-Q · filed 2023-08-11 | 14.92M shares 10-Q · filed 2023-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |